| Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national … B De Pauw, TJ Walsh, JP Donnelly, DA Stevens, JE Edwards, T Calandra, ... Clinical infectious diseases 46 (12), 1813-1821, 2008 | 6140* | 2008 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1386 | 2012 |
| Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled … JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ... The Lancet 387 (10020), 760-769, 2016 | 969 | 2016 |
| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014 | 967 | 2014 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 775 | 2014 |
| Laboratory diagnosis of invasive aspergillosis WW Hope, TJ Walsh, DW Denning The Lancet infectious diseases 5 (10), 609-622, 2005 | 760 | 2005 |
| Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology HR Ashbee, RA Barnes, EM Johnson, MD Richardson, R Gorton, ... Journal of Antimicrobial Chemotherapy 69 (5), 1162-1176, 2014 | 745 | 2014 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections MC Arendrup, T Boekhout, M Akova, JF Meis, OA Cornely, O Lortholary, ... Clinical Microbiology and Infection 20, 76-98, 2014 | 528 | 2014 |
| Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions NRH Stone, T Bicanic, R Salim, W Hope Drugs 76, 485-500, 2016 | 524 | 2016 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 507 | 2014 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ... Clinical Microbiology and Infection 18, 9-18, 2012 | 490 | 2012 |
| EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for … MC Arendrup, M Cuenca‐Estrella, C Lass‐Flörl, W Hope, EUCAST‐AFST Clinical Microbiology and Infection 18 (7), E246-E247, 2012 | 467 | 2012 |
| Therapy for fungal diseases: opportunities and priorities DW Denning, WW Hope Trends in microbiology 18 (5), 195-204, 2010 | 428 | 2010 |
| Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with … AH Groll, E Castagnola, S Cesaro, JH Dalle, D Engelhard, W Hope, ... The Lancet Oncology 15 (8), e327-e340, 2014 | 427 | 2014 |
| Tissue penetration of antifungal agents T Felton, PF Troke, WW Hope Clinical microbiology reviews 27 (1), 68-88, 2014 | 427 | 2014 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by … WW Hope, E Castagnola, AH Groll, E Roilides, M Akova, MC Arendrup, ... Clinical Microbiology and Infection 18, 38-52, 2012 | 409 | 2012 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell … AJ Ullmann, M Akova, R Herbrecht, C Viscoli, MC Arendrup, ... Clinical Microbiology and Infection 18, 53-67, 2012 | 390 | 2012 |
| The invasive and saprophytic syndromes due to Aspergillus spp. WW Hope, TJ Walsh, DW Denning Medical mycology 43 (Supplement_1), S207-S238, 2005 | 344 | 2005 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 342 | 2014 |
| F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase JD Oliver, GEM Sibley, N Beckmann, KS Dobb, MJ Slater, L McEntee, ... Proceedings of the National Academy of Sciences 113 (45), 12809-12814, 2016 | 254 | 2016 |